Heparin-induced thrombocytopaenia is a dreaded, although infrequent, complication of heparin therapy. We report two cases of heparin-induced thrombocytopaenia (HIT) type II occurring in a patient treated with standard (unfractionated) heparin and in another patient given a low-weight molecular heparin. The clinical course of the first patient illustrates the potentially severe thrombotic complications of HIT. Both cases were treated successfully by danaparoid sodium. Clues to the diagnosis and treatment are briefly discussed.
Darling, K., Jaumotte, C., Saussoy, P., Zech, F., Lavenne, E., & Hainaut, P. (2000). Heparin-induced thrombocytopaenia complicated by arterial and venous thrombosis: report of 2 cases successfully treated by a danaparoid sodium. Acta Clinica Belgica (Multilingual Edition), 55(3), 176-181. https://hdl.handle.net/2078.5/46182 (Original work published 2000)